Author： Mathier Michael A Ishizawar David
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.11, Iss.6, 2010-04, pp. : 1023-1034
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
American Journal of Cardiovascular Drugs, Vol. 2, Iss. 5, 2002-01 ,pp. :
Access to resources
Recommend
By Breu V. Ertel S.I. Roux S. Clozel M.
Expert Opinion on Investigational Drugs, Vol. 7, Iss. 7, 1998-07 ,pp. :
Bosentan: Hepatotoxicity: case report
Reactions Weekly, Vol. 1, Iss. 1092, 2006-01 ,pp. :
Bosentan: A Viewpoint by Lewis J. Rubin
By Rubin L.J.
American Journal of Cardiovascular Drugs, Vol. 2, Iss. 5, 2002-01 ,pp. :
Bosentan potentially cost effective in PAH
Inpharma, Vol. 1, Iss. 1556, 2006-01 ,pp. :